<DOC>
	<DOCNO>NCT01191450</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Chlorthalidone 25 mg + amiloride hydrochloride 5 mg association treatment elderly patient arterial hypertension .</brief_summary>
	<brief_title>Safety Efficacy Chlorthalidone + Amiloride Elderly Patients Treatment With Arterial Hypertension</brief_title>
	<detailed_description>To assess efficacy safety association Chlorthalidone 25 mg + amiloride hydrochloride 5 mg ( Diupress® Eurofarma ) treatment elderly patient arterial hypertension , compare Chlorthalidone 25mg ( Higroton® Laboratório Novartis ) presentation form . Some eligibility criterion : perform blood urine test ; ECG ( electrocardiogram ) ; ABPM ( Ambulatory Blood Pressure Monitoring ; Echocardiogram ; Doppler Echocardiogram</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>Systolic blood pressure 140 mmHg 159 mmHg Diastolic blood pressure 90 mmHg 99 mmHg Subject age ≥ 60 year old Be able comply instruction , attend study followup visit willing participate research project . Diagnosis stage 1 arterial hypertension prior treatment 120 day uncontrolled antihypertensive agent administration . Any serious severe clinically significant medical condition . Psychiatric neurological diseases A condition , per Principal Investigator 's opinion , may interfere optimal participation study , may result special risk patient . Participation investigational study within 12 month prior Visit 1 . Known medical history allergy , hypersensitivity intolerance formulation compound use study Routine prior use diuretic Oral anticoagulant use Fast glycemia &gt; 150 mg/dL Medical treatment , relate study , schedule clinical trial duration ; except nonserious , controlled comorbidities current medical followup . Expected onset additional antihypertensive drug study onset Acute myocardial infarction within last 6 month Prior decompensated coronary artery disease Known thyroid , renal liver dysfunction , investigator 's discretion Obesity body mass index ( BMI ) &gt; 33 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>chlortalidone</keyword>
	<keyword>amiloride</keyword>
	<keyword>arterial hypertension</keyword>
</DOC>